Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / B•••••••• I•••••••••

E•••••• C••••••• R•••••••, an A•••••••• C•••••• P••••••• Portfolio Company, Announces the Acquisition of B•••••••• I•••••••••

Add-on acquisitionannouncedadd-onannounced Dec 1, 2022Fact
What happened
Platform
E•••••• C••••••• R•••••••add-on basis: E•••••• C••••••• R•••••••, an A•••••••• C•••••• P••••••• Portfolio Company, Announces the Acquisition of B•••••••• I•••••••••
Control
Control
Share acquired
unknown
Industry
healthcare / clinic
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • M•••••• L•••••, a Partner at A•••••••• C•••••• P•••••••, said, “The highly complementary B•••••••• acquisition is a great start towards accelerating E••••••’s inorganic growth.
  • B•••• N•••Deal partnerconfirmed
    B•••• N•••, a Principal at A•••••••• C•••••• P•••••••, added, “This investment further expands and diversifies E••••••’s blue-chip customer base while also deepening the platform’s core capabilities in fast-growing therapeutic areas such as Oncology, Central Nervous System, and Immunology.
  • E•••••• C••••••• R•••••••, an A•••••••• C•••••• P••••••• Portfolio Company, Announces the Acquisition of B•••••••• I•••••••••
  • E•••••• C••••••• R•••••••, an A•••••••• C•••••• P••••••• Portfolio Company, Announces the Acquisition of B•••••••• I•••••••••
Side not stated
  • E•••••• C••••••• R•••••••, an A•••••••• C•••••• P••••••• Portfolio Company, Announces the Acquisition of B•••••••• I•••••••••
Evidence
E•••••• C••••••• R•••••••, an A•••••••• C•••••• P••••••• Portfolio Company, Announces the Acquisition of B•••••••• I•••••••••
E•••••• C••••••• R•••••••, an A•••••••• C•••••• P••••••• Portfolio Company, Announces the | Private Equity Intelligence | DFX